The Manufacturers Life Insurance Company Sells 11,664 Shares of Cigna Group $CI

The Manufacturers Life Insurance Company lowered its holdings in shares of Cigna Group (NYSE:CI) by 1.3% in the first quarter, Holdings Channel.com reports. The fund owned 903,875 shares of the health services provider’s stock after selling 11,664 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in Cigna Group were worth $241,109,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of CI. Wilkerson Advisory Group LLC bought a new stake in shares of Cigna Group during the fourth quarter worth $25,000. Kemnay Advisory Services Inc. purchased a new position in Cigna Group in the 4th quarter worth about $29,000. Prosperity Bancshares Inc purchased a new position in Cigna Group in the 4th quarter worth about $29,000. Cedar Mountain Advisors LLC lifted its holdings in Cigna Group by 161.9% during the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock valued at $29,000 after buying an additional 68 shares in the last quarter. Finally, Lodestone Wealth Management LLC purchased a new stake in Cigna Group in the 4th quarter valued at about $32,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Insider Activity

In other news, CAO Jamie G. Kates sold 899 shares of the firm’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the sale, the chief accounting officer directly owned 2,368 shares in the company, valued at approximately $707,108.48. This trade represents a 27.52% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO David Cordani sold 201,878 shares of Cigna Group stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the completion of the transaction, the chief executive officer directly owned 34,337 shares in the company, valued at approximately $10,054,560.34. The trade was a 85.46% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by insiders.

Cigna Group Stock Performance

Shares of CI stock opened at $291.35 on Tuesday. The firm has a market cap of $77.07 billion, a price-to-earnings ratio of 12.35, a PEG ratio of 1.12 and a beta of 0.29. Cigna Group has a 52-week low of $239.51 and a 52-week high of $315.47. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69. The company’s 50 day moving average is $286.15 and its 200 day moving average is $280.80.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The company had revenue of $68.52 billion during the quarter, compared to analyst estimates of $66.29 billion. During the same quarter in the prior year, the business earned $6.74 earnings per share. Cigna Group’s revenue was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, sell-side analysts anticipate that Cigna Group will post 30.39 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be given a dividend of $1.56 per share. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a yield of 2.1%. Cigna Group’s dividend payout ratio (DPR) is presently 26.45%.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on CI. Weiss Ratings restated a “hold (c)” rating on shares of Cigna Group in a research note on Monday, June 1st. Raymond James Financial set a $340.00 price target on shares of Cigna Group in a research note on Friday, May 1st. Wells Fargo & Company increased their price objective on Cigna Group from $300.00 to $305.00 and gave the stock an “equal weight” rating in a research note on Friday, May 1st. Royal Bank Of Canada raised their price objective on Cigna Group from $333.00 to $337.00 and gave the stock an “outperform” rating in a report on Friday, May 1st. Finally, Morgan Stanley lifted their target price on Cigna Group from $355.00 to $361.00 and gave the company an “overweight” rating in a research report on Wednesday, May 20th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $338.80.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.